Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. - Wikidata - awgldk - TriplyDB

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

http://www.wikidata.org/entity/Q30432746

about

Two-phase and family-based designs for next-generation sequencing studies Second malignant neoplasms and cardiovascular disease following radiotherapy.Medical factors influencing decision making regarding radiation therapy for breast cancer The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance Ataxia telangiectasia: a review Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.Counselling framework for moderate-penetrance cancer-susceptibility mutations.Gene--environment-wide association studies: emerging approaches Minimizing second cancer risk following radiotherapy: current perspectives.A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity Variation in base excision repair capacity.The ATM kinase induces microRNA biogenesis in the DNA damage response.Growing recognition of the role for rare missense substitutions in breast cancer susceptibility Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.Hereditary breast cancer syndromes and genetic testing.Evidence for variation in human radiosensitivity and its potential impact on radiological protection.Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.ATM, radiation, and the risk of second primary breast cancer.Dose-rate effects in radiation biology and radiation protection.A Bayesian Hierarchical Model for Relating Multiple SNPs within Multiple Genes to Disease Risk.Tests of association for rare variants: case control mutation screening.Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.Tangent field technique of TomoDirect improves dose distribution for whole-breast irradiation.Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.Cancer risk assessment using genetic panel testing: considerations for clinical application.Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review.Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways

P2860

Q26828744-14F164F3-2B44-48A6-BB56-ED241639FFE8 Q26864522-78E394C8-E70A-486C-8253-E936F7F2052C Q27005934-8553E8A0-1437-4840-809B-04698A695E02 Q28074414-B213D5BE-3DCB-4072-BC4C-5DA8D12D2A9C Q28079581-32EBB276-8486-4728-8E9D-0C0F1A0F2983 Q28743906-7B30758B-043E-4165-8022-8E925C278E3A Q30423128-CA6906B7-C4E5-4837-92AD-A05550E84AC0 Q30427359-AD530EDE-CA74-48F2-A766-48DF1418A664 Q33588213-570A6998-BA37-4115-B794-FB6D8BFB7CDD Q33911135-6B6C024E-1943-44B5-9153-CE82141ADCE7 Q33937986-910D2368-D682-4BDC-BB55-C89C6BA0FB96 Q34757180-3A51F0DD-B97E-4B21-923B-C8DCC92CE0D6 Q35002385-01C80118-B474-4B05-B838-ACC159EF3C4A Q35004482-36D58018-3A1F-4A1F-AA4E-754023505099 Q35043572-95D102D3-303A-45EA-BB61-C8895C04547D Q35106767-F679D297-C831-48F4-A2E4-BF8F21D61EEE Q35117677-F163CA7D-7BA6-49A4-AB95-96A21D079032 Q36126599-26735052-8497-4357-B430-023487793A15 Q36349558-4680F66F-6DAD-4AAF-B573-060AAA73E070 Q36910674-AF2031F9-FED5-4570-A2DA-572813EFA4BB Q38093037-9D74A827-B98D-497C-BE6B-6ECBE0597210 Q38266306-0E3C144F-2860-49D7-B29C-772C495A494E Q38766132-5C4CD216-78C6-47D6-B757-4B459C26746E Q38776757-AEB87AD4-95D1-4F51-B43B-575A691259D8 Q38979257-7979F5BE-0AFB-4A29-BF0F-B9E17E20E831 Q39382156-AE8CC724-4E57-4AE9-BAD8-578B54B88EF9 Q40862897-9470A444-7862-4DE4-8BA5-57E9A70C3840 Q41873773-7DA708C4-95F2-4686-A917-89F065029345 Q42745652-B0999DC1-303F-4400-BCDE-833AF45737DA Q43596090-36BA7AB4-244D-46A2-98CF-7EFEC16DCA04 Q44676921-EE7FE563-45C3-4D69-8C8A-4BD0585C4446 Q49993491-933BA5ED-5CEB-4634-82C4-68F18943CEDC Q50542886-648624F8-C76F-484C-9891-52BC5AC4EC17 Q51485443-889867DF-683C-49BD-AABE-AB83B85E024E Q52314057-456DD885-B6BF-4F61-8683-0E6BAE5E91C9 Q53292592-CC4967D0-9875-4FC0-8EF6-D813F364065E Q55333506-6870AB23-AE93-443D-AC1D-EDF160C940B9 Q55437668-459D657A-B49A-47E7-A194-6C699C40A731 Q57420847-60C5D2CE-97E2-4175-ADE4-05CB53BF7972 Q58695632-9DCF1BD0-FB5C-429F-8B6B-D38557CFC599

P2860

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

http://www.wikidata.org/entity/Q30432746

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@ast

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@en

type

label

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@ast

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@en

prefLabel

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@ast

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@en

P1433

Q30432746-7491B1C0-7524-4C66-87F4-D68AA5E9862A

P1476

Q30432746-2073F8A2-FE80-4684-B02C-007B536E1C7C

P2093

Q30432746-0DA310B5-F2EF-4F9E-8897-864DC01D022B

Q30432746-1EF5BC25-6287-48C6-9078-10AB2C04F376

Q30432746-269E5763-22A8-4878-86E0-98D4838778D1

Q30432746-38FCDA26-746F-472C-B74E-3838634745BA

Q30432746-39859EA7-42BA-4827-948F-7A0CE6D79C69

Q30432746-48C701E7-CD71-42E0-9920-666813BE50DF

Q30432746-526B127F-F347-4F8E-8F78-CAB177A3C2CA

Q30432746-6D24B0DE-E88B-4E2A-AA07-A6236A667866

Q30432746-8A20E0C9-02A2-40A6-8D67-2F9E53E931CB

Q30432746-91A634BE-8241-4548-8BF2-D3673F1245DA

P2860

Q30432746-0AF2B212-C4E0-4608-8AE6-F6B40BE19B2E

Q30432746-0FB961E4-E54F-4771-97F2-A97177D2D72B

Q30432746-14855F35-AF2C-4B4A-B8B3-E2C1056C6757

Q30432746-1E52C277-CA94-4ADC-8D37-FFAD04417AC5

Q30432746-1FD007D7-0028-4514-8510-30AC646EE810

Q30432746-1FFEF34F-43E9-4B4C-8D4A-356B3019A3E1

Q30432746-28BC4389-6635-4A4E-9F48-E8AF576EC71D

Q30432746-2D9D1954-7371-4369-A98C-F520B39AE775

Q30432746-2DD785CB-6748-49E6-88E2-D2B714BD832C

Q30432746-3C09FEA2-F4DD-4457-BA27-F00A44F0472E

P304

Q30432746-FAF58C2E-E430-49D3-9E8B-822FDB1B1597

P31

Q30432746-2EA61169-9884-4B37-A19E-4D17397C7108

P356

Q30432746-30BE2D5B-3F2A-4A4C-A65C-0E7CCC206216

P407

Q30432746-8A12A8EE-28CC-48FD-BEE1-9EDD9B5832DA

P433

Q30432746-553FEBA1-C888-4A9B-9217-9D7C9E82AC5C

P478

Q30432746-A43755B1-475F-4274-A849-03FF57ADFC7C

P50

Q30432746-0F2A041A-E98C-4769-8960-D05CA4736B48

Q30432746-1EE7E4FF-D84E-4729-B360-F880EB33A6B7

Q30432746-7302E51A-266B-495D-8F44-4B1B267D0A19

Q30432746-7A625386-CF00-4B6C-86C0-C8FE6C9B48EF

Q30432746-A8E9D1C4-C917-4882-8405-67329C442900

Q30432746-B22E24F4-1DB1-458E-A2B2-4B6C5957DE32

Q30432746-DBCEBFE6-C567-42E3-A1B6-08C19CB143A8

P577

Q30432746-65D73B2D-DA00-4FBA-A842-6E88E7645FE7

P5875

Q30432746-0DCB1E37-F876-4F3A-B9C5-A005BD99250C

P698

Q30432746-1B8F4B9C-21D4-401D-AB3E-371BFA8A404B

P932

Q30432746-8A83C606-211D-4967-9140-830EAF1AC98F

P356

P1433

Journal of the National Cancer Institute

P1476

Radiation exposure, the ATM Ge ...... radiation epidemiology study.

@en

P2093

Anh T Diep

http://www.w3.org/2001/XMLSchema#string

Barry S Rosenstein

http://www.w3.org/2001/XMLSchema#string

Bryan Langholz

http://www.w3.org/2001/XMLSchema#string

Charles F Lynch

http://www.w3.org/2001/XMLSchema#string

Duncan C Thomas

http://www.w3.org/2001/XMLSchema#string

John D Boice

http://www.w3.org/2001/XMLSchema#string

Jonine L Bernstein

http://www.w3.org/2001/XMLSchema#string

Jorgen H Olsen

http://www.w3.org/2001/XMLSchema#string

Kathleen E Malone

http://www.w3.org/2001/XMLSchema#string

Marilyn Stovall

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting deleterious amino acid substitutions

Dominant Negative ATM Mutations in Breast Cancer Families

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

Variation of breast cancer risk among BRCA1/2 carriers.

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

Prediction of deleterious human alleles

P304

475-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJQ055

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Lise Børresen-Dale

Patrick Concannon

Marinela Capanu

Lene Mellemkjaer

Leslie Bernstein

P577

2010-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42372092

http://www.w3.org/2001/XMLSchema#string

P698

20305132

http://www.w3.org/2001/XMLSchema#string

P932

2902825

http://www.w3.org/2001/XMLSchema#string